These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 21934576

  • 1. Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure.
    Coseo SE, Porras C, Dodd LE, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, Safaeian M, Costa Rica HPV Vaccine Trial (CVT) Group.
    Sex Transm Dis; 2011 Oct; 38(10):976-82. PubMed ID: 21934576
    [Abstract] [Full Text] [Related]

  • 2. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
    Coseo S, Porras C, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Wang SS, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, Safaeian M, Costa Rica HPV Vaccine Trial (CVT) Group.
    Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
    [Abstract] [Full Text] [Related]

  • 3. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.
    Safaeian M, Porras C, Schiffman M, Rodriguez AC, Wacholder S, Gonzalez P, Quint W, van Doorn LJ, Sherman ME, Xhenseval V, Herrero R, Hildesheim A, Costa Rican Vaccine Trial Group.
    J Natl Cancer Inst; 2010 Nov 03; 102(21):1653-62. PubMed ID: 20944077
    [Abstract] [Full Text] [Related]

  • 4. Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus.
    Robbins HA, Li Y, Porras C, Pawlita M, Ghosh A, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Gonzalez P, Schiller J, Lowy D, Esser M, Matys K, Quint W, van Doorn LJ, Herrero R, Pinto LA, Hildesheim A, Waterboer T, Safaeian M.
    BMC Infect Dis; 2014 Mar 03; 14():120. PubMed ID: 24588945
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay.
    Robbins HA, Waterboer T, Porras C, Kemp TJ, Pawlita M, Rodriguez AC, Wacholder S, Gonzalez P, Schiller JT, Lowy DR, Esser M, Matys K, Poncelet S, Herrero R, Hildesheim A, Pinto LA, Safaeian M.
    Hum Vaccin Immunother; 2014 Mar 03; 10(10):2965-74. PubMed ID: 25483632
    [Abstract] [Full Text] [Related]

  • 6. Determinants of seropositivity among HPV-16/18 DNA positive young women.
    Porras C, Bennett C, Safaeian M, Coseo S, Rodríguez AC, González P, Hutchinson M, Jiménez S, Sherman ME, Wacholder S, Solomon D, van Doorn LJ, Bougelet C, Quint W, Schiffman M, Herrero R, Hildesheim A, Costa Rica HPV Vaccine Trial (CVT) Group.
    BMC Infect Dis; 2010 Aug 11; 10():238. PubMed ID: 20698998
    [Abstract] [Full Text] [Related]

  • 7. Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates.
    Lang Kuhs KA, Porras C, Schiller JT, Rodriguez AC, Schiffman M, Gonzalez P, Wacholder S, Ghosh A, Li Y, Lowy DR, Kreimer AR, Poncelet S, Schussler J, Quint W, van Doorn LJ, Sherman ME, Sidawy M, Herrero R, Hildesheim A, Safaeian M, Costa Rica Vaccine Trial Group.
    Am J Epidemiol; 2014 Sep 15; 180(6):599-607. PubMed ID: 25139208
    [Abstract] [Full Text] [Related]

  • 8. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
    Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT.
    J Natl Cancer Inst; 1994 Apr 06; 86(7):494-9. PubMed ID: 8133532
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping.
    Castle PE, Sadorra M, Lau T, Aldrich C, Garcia FA, Kornegay J.
    J Clin Microbiol; 2009 Oct 06; 47(10):3344-7. PubMed ID: 19675214
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial.
    Safaeian M, Porras C, Pan Y, Kreimer A, Schiller JT, Gonzalez P, Lowy DR, Wacholder S, Schiffman M, Rodriguez AC, Herrero R, Kemp T, Shelton G, Quint W, van Doorn LJ, Hildesheim A, Pinto LA, CVT Group.
    Cancer Prev Res (Phila); 2013 Nov 06; 6(11):1242-50. PubMed ID: 24189371
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial.
    Lang Kuhs KA, Gonzalez P, Rodriguez AC, van Doorn LJ, Schiffman M, Struijk L, Chen S, Quint W, Lowy DR, Porras C, DelVecchio C, Jimenez S, Safaeian M, Schiller JT, Wacholder S, Herrero R, Hildesheim A, Kreimer AR, Costa Rica Vaccine Trial Group.
    J Infect Dis; 2014 Dec 15; 210(12):1890-9. PubMed ID: 24958910
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica.
    Lang Kuhs KA, Gonzalez P, Struijk L, Castro F, Hildesheim A, van Doorn LJ, Rodriguez AC, Schiffman M, Quint W, Lowy DR, Porras C, Delvecchio C, Katki HA, Jimenez S, Safaeian M, Schiller J, Solomon D, Wacholder S, Herrero R, Kreimer AR, Costa Rica Vaccine Trial Group.
    J Infect Dis; 2013 Nov 15; 208(10):1643-52. PubMed ID: 24014882
    [Abstract] [Full Text] [Related]

  • 19. Empirical sample-specific approaches to define HPV16 and HPV18 seropositivity in unvaccinated, young, sexually active women.
    Ng K, Morais S, Wissing MD, Burchell AN, Tellier P-P, Coutlée F, Waterboer T, El-Zein M, Franco EL.
    Microbiol Spectr; 2024 Jun 04; 12(6):e0022924. PubMed ID: 38687066
    [Abstract] [Full Text] [Related]

  • 20. Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.
    Beachler DC, Kreimer AR, Schiffman M, Herrero R, Wacholder S, Rodriguez AC, Lowy DR, Porras C, Schiller JT, Quint W, Jimenez S, Safaeian M, Struijk L, Schussler J, Hildesheim A, Gonzalez P, Costa Rica HPV Vaccine Trial (CVT) Group.
    J Natl Cancer Inst; 2016 Jan 04; 108(1):. PubMed ID: 26467666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.